DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

100 Folgen

1. DrugPatentWatch Week in Review

   Vom: 22.3.2022
2. 2 Strategies to Grow Your Excipient Business by Tracking Drug Patents

   Vom: 22.3.2022
3. Free Online Course on Drug Patents, Generic and Branded Drugs

   Vom: 10.3.2022
4. DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform

   Vom: 20.10.2021
5. DrugPatentWatch Custom Market Surveillance

   Vom: 20.10.2021
6. Updating the DrugPatentWatch Biologics Module

   Vom: 20.10.2021
7. Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades

   Vom: 20.10.2021
8. Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review

   Vom: 12.10.2021
9. Generic Portfolio Management, Partnering with Brands, and Staying Competitive

   Vom: 4.10.2021
10. Upcoming workshop on generic portfolio management

    Vom: 16.8.2021
11. DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management

    Vom: 16.7.2021
12. Strategies for Pricing Generic Drugs

    Vom: 8.6.2021
13. Free Course in Generic and Branded Drug Lifecycle Management

    Vom: 3.6.2021
14. Stop paying your staff to make repetitive reports

    Vom: 7.4.2021
15. Connecting Excipients with Drug Patents – New DrugPatentWatch module

    Vom: 8.3.2021
16. Say ‘NO’ to Bad Contracts

    Vom: 11.2.2021
17. The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA

    Vom: 3.2.2021
18. DrugPatentWatch featured in Inc Magazine

    Vom: 2.2.2021
19. Pharmaceutical procurement practice aspects

    Vom: 7.1.2021
20. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet

    Vom: 5.1.2021